Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EuroGIOPs: Teriparatide vs Risedronate in Men with GIOP
NCT00503399Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2007
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of teriparatide in glucocorticoid-induced osteoporosis (GIOP), sponsored by Eli Lilly and Company. Started Jul 2007; status: completed.
02
Drugs
teriparatide
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT00503399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503399.